Actively Recruiting

Age: 18Years +
All Genders
ID03228290

Functional Assessment in Liver Transplant Candidates (FrAILT) Study

Led by University of California, San Francisco · Updated on 2025-07-04

5000

Participants Needed

12

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

N

National Institute on Aging (NIA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a prospective cohort study involving adults with liver disease who are candidates for liver transplantation. The study aims to assess frailty, functional status, and disability using various functional measures. It also evaluates quality of life, personality, and cognitive function through questionnaires and cognitive tests. The purpose is to understand how frailty and physical function relate to outcomes before and after liver transplantation. Participants will undergo assessments including cognitive tests, quality of life evaluations, and physical performance measures such as grip strength, chair stands, balance, gait speed, and interviews regarding exhaustion and activity levels. Laboratory tests like creatinine, bilirubin, INR, sodium, and albumin will be collected from medical records. A subgroup of 1000 patients will provide blood, urine, stool, and tissue samples during transplant surgery for further study. Assessments will be done at baseline and at every clinic visit before transplant, continuing through 12 months post-transplant, then annually afterward. Researchers will track changes in frailty and physical function over time using the Liver Frailty Index. The study will monitor these measures to examine their association with transplant outcomes and overall patient health during follow-up periods lasting several years.

CONDITIONS

Brief Title

Functional Assessment in Liver Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult (≥18 years old)
  • Are seen for the treatment of liver disease
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Ongoing throughout study participation

Participants undergo assessments of cognitive function, quality of life, personality, and measures of frailty and disability including grip strength, chair stands, balance testing, and gait speed.

Visits occur as participants are seen for liver disease treatment

Sample Collection

Duration - During the course of treatment and surgery as applicable

Blood draw, urine, and stool samples are collected for a sub-group of participants. Additional tissue samples are collected during liver transplant surgery for this sub-group.

Sample collection occurs during clinical visits and surgery

Long-term Monitoring

Duration - Up to study completion on December 31, 2028

Participants are observed for changes in frailty, physical function, and liver transplant outcomes before and after liver transplantation.

Follow-up assessments occur during routine care visits

Trial Site Locations

Total: 12 locations

1

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205

Completed

2

Loma Linda University

Loma Linda, California, United States, 92354

Completed

3

University of California, San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

4

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

5

Indiana University

Indianapolis, Indiana, United States, 46202

Active, Not Recruiting

6

Johns Hopkins

Baltimore, Maryland, United States, 21287

Actively Recruiting

7

University of Michigan

Ann Arbor, Michigan, United States, 48109

Completed

8

Columbia University

New York, New York, United States, 10032

Actively Recruiting

9

Duke University Medical Center

Durham, North Carolina, United States, 27710

Actively Recruiting

10

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15237

Actively Recruiting

11

Baylor Scott & White Health

Dallas, Texas, United States, 75246

Actively Recruiting

12

University of Washington

Seattle, Washington, United States, 98195

Actively Recruiting

Loading map...

Research Team

J

Jennifer C Lai, MD, MBA

F

Fawzy Barry, BS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A 12-Month, Open-Label Study Evaluating Safety, Tolerability...

Autoimmune Liver Disease

Actively Recruiting

1 location

Adverse Outcomes and Mortality in Liver Transplant Using MRI...

End Stage Liver DIsease

Actively Recruiting

1 location

A Phase 2a, Open Label, Dose Escalation Study for Safety, To...

End Stage Liver Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.

Jennifer C Lai, Kenneth E Covinsky, Hilary Hayssen...

https://pubmed.ncbi.nlm.nih.gov/25644788

Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.

Connie W Wang, Kenneth E Covinsky, Sandy Feng...

https://pubmed.ncbi.nlm.nih.gov/26359787

Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.

Jennifer C Lai, Jennifer L Dodge, Saunak Sen...

https://pubmed.ncbi.nlm.nih.gov/26517301

A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.

Connie W Wang, Sandy Feng, Kenneth E Covinsky...

https://pubmed.ncbi.nlm.nih.gov/27314169

Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.

Marie Sinclair, Eduard Poltavskiy, Jennifer L Dodge...

https://pubmed.ncbi.nlm.nih.gov/28223735